Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

463
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
463
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

309
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
309
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

297
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
297
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

135
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
135
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

504
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
504

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing population.

The pharmacogenomics journal·2026
Same author

Clinical Pharmacists and Industry: Guidelines for Professional Interactions.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Clinician Satisfaction With Pharmacogenomics Clinical Services at a Multistate Health System.

Clinical and translational science·2026
Same author

Aripiprazole and CYP2D6: A retrospective cohort study evaluating the impact of phenotype on metabolic abnormalities.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2025
Same author

Analyzing the impact of pharmacogenomics-guided nonsteroidal anti-inflammatory drug alerts in clinical practice.

JAMIA open·2025
Same author

Evaluation of pharmacogenetic automated clinical decision support for clopidogrel.

Pharmacogenomics·2024

相关实验视频

Updated: Jan 9, 2026

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

7.0K

开发一种基于统计建模的机器学习方法,用于捕获使用质子抑制剂的药物剂量.

Amanda Massmann1,2, Jordan F Baye1,2,3, Max Weaver1

  • 1Sanford Health, Sioux Falls, South Dakota, USA.

Pharmacotherapy
|December 1, 2025
PubMed
概括

一个新的统计模型从电子健康记录 (EHR) 中准确地捕捉了质子抑制剂 (PPI) 的剂量. 这种机器学习方法解决了药物管理中的变化和复杂性,以改善患者护理.

关键词:
算法算法是一种算法.电子健康记录是电子健康记录.自然语言处理自然语言处理.神经网络的神经网络的神经网络药品制剂是药品制剂中的一种.质子抑制剂 质子抑制剂监督机器学习是指监督机器学习.

更多相关视频

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.0K
A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

17.5K

相关实验视频

Last Updated: Jan 9, 2026

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays
06:13

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

7.0K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.0K
A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

17.5K

科学领域:

  • 制药指标 (Pharmacometrics) 是一个指标.
  • 医疗信息学 医疗信息学
  • 医疗保健中的机器学习

背景情况:

  • 质子抑制剂 (PPI) 被广泛使用,但从电子健康记录 (EHR) 中准确捕捉其剂量,由于其变异性和复杂性而存在挑战.
  • 结构化EHR数据为开发自动化药物剂量模型提供了潜力.

研究的目的:

  • 开发和评估一个统计模型,以捕捉质子抑制剂 (PPI) 药物剂量,使用电子健康记录 (EHR) 的结构化数据.

主要方法:

  • 从单一医疗保健系统的EHR中提取了近20年的PPI处方数据.
  • 25%的独特剂量方案由临床药剂师手动标记,用于模型培训和验证.
  • 训练并评估了几种机器学习模型,包括一个堆叠组合模型,使用回归指标 (RMSE,R平方).

主要成果:

  • 该研究分析了17,271名患者和186,801个独特的PPI订单,确定了10,739个独特的药物实体.
  • 一个堆叠的整体模型以0.09的根平均平方误差 (RMSE) 和0.825.82的R平方值实现了最佳性能.
  • 该模型在捕捉PPI剂量方面表现出高灵敏度和准确性.

结论:

  • 开发了一个高度敏感和准确的统计模型来捕捉PPI剂量,包括复杂的策略.
  • 监督学习模型可以有效地解决药物剂量识别方面的挑战.
  • 未来的工作应该整合非结构化的EHR数据,以进一步提高药物剂量捕获精度.